نتائج البحث - "Patricia Martin Romano"

1

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

المساهمون: Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonary Medicine

المصدر: EUROPEAN JOURNAL OF CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
European Journal of Cancer, 151, 211-220. ELSEVIER SCI LTD
European Journal of Cancer, 151, 211-220. Elsevier Ltd.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Time Factors, Neutrophils, medicine.medical_treatment, NSCLC, Leukocyte Count, 0302 clinical medicine, Immunophenotyping, MARKERS, Carcinoma, Non-Small-Cell Lung, Prospective Studies, Immune Checkpoint Inhibitors, DOCETAXEL, Aged, 80 and over, Middle Aged, Flow Cytometry, Europe, Phenotype, Treatment Outcome, Docetaxel, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Immunotherapy, Biomarker, dNLR, Nivolumab, medicine.drug, Adult, medicine.medical_specialty, BIOMARKERS, 03 medical and health sciences, Young Adult, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Internal medicine, medicine, Humans, In patient, CELL, Lung cancer, Aged, Retrospective Studies, business.industry, NIVOLUMAB, medicine.disease, United States, 030104 developmental biology, Biological significance, Drug Resistance, Neoplasm, INHIBITORS, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a96c55a9d472fb0598bd6fb82e8daceTest
https://doi.org/10.1016/j.ejca.2021.03.011Test

2

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?

المؤلفون: Antonin Levy, Stéphane Champiat, Jean-Yves Scoazec, Aurélien Marabelle, Patricia Martin-Romano, Eric Deutsch, Christophe Massard, Jean-Charles Soria, Julien Adam, Sebastien Gouy, Capucine Baldini, Antoine Hollebecque

المصدر: Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66e4dd55c5370e526b8fee751e756921Test
http://europepmc.org/articles/PMC8600981Test

3

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

المصدر: European Journal of Cancer. 129:71-79

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Aging, Cancer Research, medicine.medical_specialty, Weakness, Drug-Related Side Effects and Adverse Reactions, Programmed Cell Death 1 Receptor, Kaplan-Meier Estimate, Severity of Illness Index, B7-H1 Antigen, Pharmacovigilance, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, Risk Factors, Neoplasms, Internal medicine, medicine, Adverse Drug Reaction Reporting Systems, Humans, Prospective Studies, Risk factor, Adverse effect, Aged, Aged, 80 and over, business.industry, Incidence, Patient Selection, Incidence (epidemiology), Age Factors, Immunosenescence, Immune checkpoint, Nivolumab, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, France, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8e9d56be54b42bfa7ed3787ae48ffbTest
https://doi.org/10.1016/j.ejca.2020.01.013Test

4

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors

المصدر: Cancers, Vol 13, Iss 3776, p 3776 (2021)
Cancers
Volume 13
Issue 15

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d8359793954215378670b8aff62b88Test
https://www.mdpi.com/2072-6694/13/15/3776Test

5

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic

المؤلفون: Patricia Martin-Romano, Capucine Baldini, Stefan Michiels, Jean-Charles Soria, Arnaud Bayle, Stéphane Champiat, Antoine Hollebecque, Christophe Massard, Laurence Albiges, Daphné Morel, Rastilav Bahleda, Jean-Marie Michot, Fabrice Barlesi, Anas Gazzah, Loic Verlingue, Benjamin Besse, Arthur Geraud, Sophie Postel-Vinay, Aurélien Marabelle

المصدر: Cancer Cell

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9e1ba338b2dd55247beb78171f87248Test
http://europepmc.org/articles/PMC8243022Test

6

Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities

المصدر: European journal of cancer (Oxford, England : 1990). 157

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1483b4b99b2d5a1d5425c49704be64Test
https://pubmed.ncbi.nlm.nih.gov/34571335Test

7

MET Receptor Amplification Drives Resistance to Anti-EGFR Therapies

المؤلفون: Ludovic Lacroix, Lambros Tselikas, Eric Angevin, Antoine Hollebecque, Sami Ammari, Patricia Martin Romano, Nathalie Auger, Jean-Charles Soria, Eduardo Castanon, Christophe Massard

المصدر: Journal of Immunotherapy and Precision Oncology. 2:152-155

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5c9dab8c173c39a83d4845a9744ee460Test
https://doi.org/10.4103/jipo.jipo_7_19Test

8

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

المؤلفون: Patricia Martin-Romano, Benjamin Besse, Christophe Massard, Caroline Even, Anne-Laure Voisin, Aurélien Marabelle, Capucine Baldini, Laurence Albiges, A. Laparra, Jean-Marie Michot, Olivier Lambotte, P. Vuagnat, Stéphane Champiat, A. Simonaggio, François-Xavier Danlos, Maria Kfoury, Caroline Robert, Christine Mateus, Salim Laghouati

المصدر: Annals of Oncology. 32:936-937

مصطلحات موضوعية: Oncology, medicine.medical_specialty, biology, Surrogate endpoint, business.industry, MEDLINE, Cancer, Hematology, medicine.disease, B7-H1 Antigen, Clinical trial, Immune system, Neoplasms, Internal medicine, Programmed cell death 1, medicine, biology.protein, Humans, Immunotherapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af2d59ff08b70254c9937d2245552c4Test
https://doi.org/10.1016/j.annonc.2021.04.006Test

9

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

المؤلفون: Mariona Riudavets, Laura Mezquita, Pernelle Lavaud, David Planchard, F. Blanc-Durand, Lamiae El-Amarti, Caroline Caramella, Julien Adam, C. Naltet, Gala Martinez, Edouard Auclin, Jose Carlos Benitez, Nathalie Chaput, Patricia Martin-Romano, Lizza E.L. Hendriks, Roberto Ferrara, Andrea De Giglio, Benjamin Besse, Anas Gazzah

المساهمون: Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Cancers, Vol 12, Iss 2827, p 2827 (2020)
Cancers, 12(10):2827. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 12
Issue 10

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Prognostic factor, Immune checkpoint inhibitors, medicine.medical_treatment, non-small cell lung cancer (NSCLC), lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Retrospective analysis, Overall survival, polycyclic compounds, PEMBROLIZUMAB, non-small cell lung cancer, RISK, business.industry, Cancer, Immunotherapy, ASSOCIATION, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 030104 developmental biology, Steroid use, 030220 oncology & carcinogenesis, immunotherapy, business, hormones, hormone substitutes, and hormone antagonists, steroids

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcefc03f059cd6dca60d0d6d6b96fa42Test
https://www.mdpi.com/2072-6694/12/10/2827Test

10

Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 27(2)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Context (language use), Antineoplastic Agents, Neutropenia, Neuroendocrine tumors, Gastroenterology, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Refractory, Pharmacokinetics, Cancer stem cell, Paraganglioma, Internal medicine, Neoplasms, medicine, Humans, Organic Chemicals, Fatigue, Aged, Dose-Response Relationship, Drug, business.industry, Lymphoma, Non-Hodgkin, Middle Aged, medicine.disease, Thrombocytopenia, Lymphoma, 030104 developmental biology, Treatment Outcome, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Area Under Curve, Female, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec2d683144ba618e349a3cd99581434Test
https://pubmed.ncbi.nlm.nih.gov/33046517Test

تنقيح النتائج